FDA Approved: DAYBUE — Supplemental Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for DayBUE (trofinetide) from Acadia Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• DAYBUE (trofinetide)

Snippet

SUPPL AP for DAYBUE (TROFINETIDE)